Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)
Investigative Ophthalmology & Visual Science · 2025
DOI: 10.1167/iovs.66.2.15 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Ophthalmology & Visual Science, 2025. Verfasst von Hao Chi und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China. Hauptthemen laut MEDLINE: Graft Rejection, Corneal Transplantation, Aniline Compounds, Sulfonamides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory Cultivation Base, Shandong Key Laboratory of Eye Diseases, Eye Institute of Shandong First Medical University, Qingdao, China.
- Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences, Qingdao, China.
- School of Ophthalmology, Shandong First Medical University, Jinan, China.
- Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Eye Institute of Shandong First Medical University, Jinan, China.
- Eye Institute of Shandong First Medical University, Qingdao Eye Hospital of Shandong First Medical University, Qingdao, China.
- https://orcid.org/0000-0003-1581-8377.
Zitieren
APA
Chi, H., Ma, L., Zeng, F., Wang, X., Peng, P., Bai, X., Zhang, T., Yin, W., Yu, Y., Yang, L., Zhou, Q., Wei, C., & Shi, W. (2025). Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.66.2.15
Vancouver
Chi H, Ma L, Zeng F, Wang X, Peng P, Bai X, et al. Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2). Investigative Ophthalmology & Visual Science. 2025. doi:10.1167/iovs.66.2.15
BibTeX
@article{Chi2025,
author = {Chi, Hao and Ma, Li and Zeng, Fanxing and Wang, Xiaolei and Peng, Peng and Bai, Xiaofei and Zhang, Ting and Yin, Wenhui and Yu, Yaoyao and Yang, Lingling and Zhou, Qingjun and Wei, Chao and Shi, Weiyun},
title = {Senolytic Treatment Alleviates Corneal Allograft Rejection Through Upregulation of Angiotensin-Converting Enzyme 2 (ACE2)},
journal = {Investigative Ophthalmology & Visual Science},
year = {2025},
doi = {10.1167/iovs.66.2.15}
}
EUVIMED